[EN] 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES<br/>[FR] QUINAZOLINES 4-ANILIDO SUBSTITUEES ET UTILISATION DE CELLES-CI COMME INHIBITEURS DES KINASES DU RECEPTEUR DU FACTEUR DE CROISSANCE DE L'EPIDERME
申请人:YISSUM RES DEV CO
公开号:WO2004013091A2
公开(公告)日:2004-02-12
The present invention provides 4-anilido substituted quinazoline compounds which are potent inhibitors of protein tyrosine kinase (PTK) activity, particularly epidermal growth factor receptor (EGFR) kinase activity, and pharmaceutical composition comprising these compounds. The quinazoline compounds are useful in treating a variety of PTK related disorders such as cell proliferative disorders, fibrotic disorders, metabolic disorders and cancer.